Hanover - Delayed Quote EUR

Gilead Sciences Inc (GIS.HA)

93.41

+2.92

+(3.23%)

At close: April 14 at 5:25:09 PM GMT+2

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.

The Wall Street Journal 3 days ago

ALNY

GILD

LLY
Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025

FOSTER CITY, Calif., April 10, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2025 financial results and guidance will be released on Thursday, April 24, 2025 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s first quarter 2025 financial results and provide a business update.

Business Wire 4 days ago

GILD
PatientView Ranks Gilead "Best" at ESG

NORTHAMPTON, MA / ACCESS Newswire / April 10, 2025 / At Gilead, putting people first is central to all we do. That's why we're proud to be recognized as a responsible company by patient advocacy groups representing more than 70 countries. In a new ...

ACCESS Newswire 4 days ago

GILD
Gilead Sciences (GILD) Increases Yet Falls Behind Market: What Investors Need to Know

In the closing of the recent trading day, Gilead Sciences (GILD) stood at $105.25, denoting a +2% change from the preceding trading day.

Zacks 5 days ago

GILD
Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report?

Gilead (GILD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 5 days ago

GILD
Multiple Tailwinds Lifted Gilead Sciences (GILD) in Q1

ClearBridge Investments, an investment management company, released its “ClearBridge Value Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the strategy underperformed its Russell 1000 Value benchmark, driven by detractors in the energy and financials, which overcame contributions from overweight to energy and underweight to […]

Insider Monkey 5 days ago

GILD
2 Top Dividend Stocks That Could Set You Up for Life

With equity markets in shambles due to President Donald Trump's trade policies, now might be as good a time as any to invest in excellent dividend stocks. With that said, let's consider two top dividend stocks that should navigate the current storm relatively well and continue performing long after: AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD). AbbVie went public in 2013, splitting from its former parent company, Abbott Laboratories.

Motley Fool 5 days ago

ABBV

GILD
Gilead Sciences: The Global Health Challenge of HIV and Hepatitis B Coinfections

NORTHAMPTON, MA / ACCESS Newswire / April 8, 2025 / In 2019, Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with hepatitis B (HBV) and with advanced HIV. "Since both viruses ...

ACCESS Newswire 6 days ago

GILD
Is Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Gilead (GILD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Zacks 7 days ago

GILD
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues

Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.

Zacks 10 days ago

^GSPC

FME.DE

GILD
Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note

Gilead Sciences (GILD) reachead $112.39 at the closing of the latest trading day, reflecting a +0.45% change compared to its last close.

Zacks 11 days ago

GILD

^GSPC
Gilead Sciences (GILD) Ascends But Remains Behind Market: Some Facts to Note

In the most recent trading session, Gilead Sciences (GILD) closed at $111.88, indicating a +0.54% shift from the previous trading day.

Zacks 12 days ago

GILD

^GSPC
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 12 days ago

GILD
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.

Zacks 12 days ago

GILD
Biotech stocks slide as Marks resignation seen being negative for sector

Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors. “NOT GOOD” FOR BIOTECH SECTOR: RBC Capit

TipRanks 13 days ago

GLPG

GLPGF

PTCT
GILD or AMGN: Which Is the Better Value Stock Right Now?

GILD vs. AMGN: Which Stock Is the Better Value Option?

Zacks 13 days ago

AMGN

GILD
Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV

NORTHAMPTON, MA / ACCESS Newswire / April 1, 2025 / In 2006, Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground around the globe and existing therapies were limited. He was 12 years ...

ACCESS Newswire 13 days ago

GILD
These biotech names aren't facing 'huge concern' from tariffs

Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with overseas production. Jefferies managing director Michael Yee joins Market Domination Overtime to discuss how tariffs could impact the biotech sector, emphasizing Vertex (VRTX), Amgen (AMGN), and Gilead (GILD) as some of his top large-cap picks in the sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 13 days ago

GILD

VRTX

AMGN
Moderna, biotech stocks slide following resignation of FDA official Peter Marks

The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.

Yahoo Finance 14 days ago

DVAX

PCVX

NVAX
1 Healthcare Stock to Target This Week and 2 to Turn Down

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 11.1%. This drop was worse than the S&P 500’s 4% decline.

StockStory 14 days ago

RVTY

GILD

JNJ

Performance Overview

Return	GIS.HA	S&P 500 (^GSPC)
YTD	+4.70%	-8.09%
1-Year	+51.90%	+5.52%
3-Year	+86.35%	+23.07%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Gilead Sciences Inc (GIS.HA)

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025

PatientView Ranks Gilead "Best" at ESG

Gilead Sciences (GILD) Increases Yet Falls Behind Market: What Investors Need to Know

Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report?

Multiple Tailwinds Lifted Gilead Sciences (GILD) in Q1

2 Top Dividend Stocks That Could Set You Up for Life

Gilead Sciences: The Global Health Challenge of HIV and Hepatitis B Coinfections

Is Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic?

4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues

Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note

Gilead Sciences (GILD) Ascends But Remains Behind Market: Some Facts to Note

Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know

Biotech stocks slide as Marks resignation seen being negative for sector

GILD or AMGN: Which Is the Better Value Stock Right Now?

Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV

These biotech names aren't facing 'huge concern' from tariffs

Moderna, biotech stocks slide following resignation of FDA official Peter Marks

1 Healthcare Stock to Target This Week and 2 to Turn Down

Performance Overview